Isolation of a variant which has reduced Src activity from SH-SY5Y neuroblastoma cells

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3311-3314

  Hiwasa, Takaki ^a   Nakamura, Yohko ^b   Sakiyama, Shigeru ^b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

Apoptosis; Herbimycin A; Neuroblastoma; Src; Survival

Indexed keywords

HERBIMYCIN A;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BENZOQUINONES; CELL SURVIVAL; ENZYME INHIBITORS; HUMANS; LACTAMS, MACROCYCLIC; NEUROBLASTOMA; QUINONES; SRC-FAMILY KINASES; TUMOR CELLS, CULTURED;

EID: 0031730992     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sefton BM, Hunter T, Beemon K and Eckhalt W: Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 20: 807-816, 1980.
2. Takeya T and Hanafusa H: Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell 32: 881-890, 1983.
3. Bjorge AD, O'Connor TJ and Fujita DJ: Activation of human pp60c-src. Biochem Cell Biol 74: 477-484, 1996.
4. Frish SM and Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
5. Canman CC, Gilmer TM, Coutts SB and Kastan MB: Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Develop 9: 600-611, 1995.
6. Alemà S, Casalbore P, Agostini E and Tato F: Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene. Nature 316: 557-559, 1985.
7. c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. Science 237: 411-415, 1987.
8. Uehara Y, Hori M, Takeuchi T and Umezawa H: Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kedney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res 76: 672-675, 1985.
9. src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6: 2198-2206, 1986.
10. Nakagawara A, Azar CG, Scavarda NJ and Brodeur GM: Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 759-767, 1994.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
12. Hiwasa T, Soeda C, Takanohashi S, Kobayashi H, Suzuki A, Ueyama T and Ike Y: Screening of peptides which suppress the proliferation of transformed cells. Int J Oncol 8: 125-129, 1996.
13. Hiwasa T, Tokita H and Ike Y: Differential chemosensitivity in oncogene-transformed cells. J Exper Ther Oncol 1: 162-170, 1996.
14. Kikuchi H and Imajoh-Ohmi S: Activation and possible involvement of calpain, a calcium-activated cysteine protease, in down-regulation of apoptosis of human monoblast U937 cells. Death and Differ 2: 195-199, 1995.
15. Hiwasa T and Kominami E: Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells. Biochem Biophys Res Commun 216: 828-834, 1995.
16. Hiwasa T, Sawada T and Sakiyama S: Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward N1H3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells. Carinogenesis 11: 75-80, 1990.
17. Hiwasa T and Ohkoshi M: Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblasts. Anticancer Res 16: 1823-1826, 1996.
18. Soriano P, Montgomery C, Geske R and Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702, 1991.